This is an aggregated industry headline. Read the full story at Drug Channels →
Drug Channels News Roundup, Mid-June 2026: Biosimilar Development Barriers, Hospital Specialty Pharmacy Growth, Medicaid Incentives, Drug Pricing Tradeoffs, and the Prescription-Filling Process
By Bryce Platt, PharmD Summer officially starts this weekend! Consider doing a few of your lifting sets (or work meetings) outside. The healthier you are, the longer you'll be able to read our news roundups, so everybody wins! In this issue: A Leaky Biosimilar Funnel Reasons for Growth in Hospital S
By Drug Channels
· Jun 17, 2026
· via Drug Channels
RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.
Tags
theweekformat:headlineheadlineDrug Channels
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
Pfizer's CFO Dave Denton will officially depart in August, leaving SVP of finance Cecile Guegan to take up his…
The WeekFierceBiotech ↗
Zoll Medical, the maker of devices and software focused on cardiopulmonary and respiratory conditions, was sla…
The WeekBriefing
PwC says pharma and life sciences deals topped $65B in Q1 2026, led by big-ticket buys from Sun Pharma and GSK…